{"id":"W4409533993","doi":"10.1016/j.jpet.2025.103584","title":"A phase 1, first-in-human, open label, single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of stabilized isoamyl nitrite nasal spray in healthy adult participants","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"Biomedical Advanced Research and Development Authority; U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response","keywords":"Pharmacokinetics; Pharmacodynamics; Tolerability; Pharmacology; Medicine; Open label; Anesthesia; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001636552,0.001235939,0.001299362,0.0002076034,0.0005582439,0.0005918847,0.0005174936,0.0008872832,0.003353517],"category_scores_gemma":[0.0008257539,0.0005093102,0.0007017279,0.0001769883,0.0007090042,0.0007150542,0.0001982677,0.001801771,0.0006553612],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005442234,"about_ca_system_score_gemma":0.001812807,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009195655,"about_ca_topic_score_gemma":0.003404482,"domain_scores_codex":[0.999608,0.0001533551,0.0000162157,0.0001011995,0.00005809103,0.00006327999],"domain_scores_gemma":[0.9994069,0.00007892503,0.000164182,0.00005832401,0.00009473696,0.0001969478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3886875,0.1849099,0.01594811,0.001673734,0.001458724,0.0005805357,0.001057524,0.002338627,0.2918171,0.0004047941,0.006764401,0.1043591],"study_design_scores_gemma":[0.05617714,0.9122239,0.01635243,0.00002811958,0.0002733829,0.0002493383,0.0001487669,0.0008216311,0.009688717,0.0001535428,0.003856764,0.00002625836],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902233,0.0007772718,0.001722899,0.0002474858,0.00009690555,0.004836343,0.001025374,0.00008762389,0.0009826948],"genre_scores_gemma":[0.9818769,0.00109588,0.004833337,0.001127535,0.0001200088,0.00417539,0.001352297,0.00003918204,0.005379494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003353517,"threshold_uncertainty_score":0.01121861,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0944381067161559,"score_gpt":0.4870004497431855,"score_spread":0.3925623430270295,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}